Arkolith/Insider Trading/CHRS/Form 4

Lanfear Dennis M

President & CEO, DirectorCoherus BioSciences, Inc. (CHRS) · full profile →Form 4 · filed Jan 8, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 4, 2024Tax withholding(F)12K$2.92$34K720K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 5, 2024Grant(A)575K—$0575K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-24-000019) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML